Skip to content

Oxytocin Administration Prior Planned Caesarean Section

Mild Induced Labour Prior to Planned Caesarean Delivery to Improve Neonatal and Maternal Outcome - a Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03693885
Enrollment
1450
Registered
2018-10-03
Start date
2019-01-01
Completion date
2025-06-01
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding Status, Respiratory Insufficiency Syndrome of Newborn

Keywords

caesarean section, Oxytocin challenge test

Brief summary

Spontaneous vaginal delivery of a healthy infant provokes a unique surge in stress hormone concentrations (e.g. AVP (arginine vasopressin) /copeptin) incommensurable with child or adult levels measured in any other situation. In contrast, infants delivered by primary caesarean section without preceding labour have low stress hormone concentrations at birth unless other stressors are present, including chorioamnionitis or intrauterine growth restriction. Infants delivered by caesarean section after a trial of labour show copeptin concentrations between these two extremes. Objectives:1) To reduce neonatal respiratory morbidity and admission to the Neonatal Intensive Care Unit and increase bonding and breastfeeding by triggering uterine contractions prior to planned caesarean delivery. 2\) To collect prospectively weight data of infants in the first 6 months of life to validate and expand our online neonatal weight calculator. Study design: Open label; randomised, placebo controlled trail Intervention: Oxytocin challenge test (OCT): Infusion of oxytocin 5 IU/500 ml Ringer® lactate at a rate of 12 ml/h and doubled every 10 min until three uterine contractions per 10-min interval are induced, at which point it will be stopped. Primary endpoint: \- Incidence of neonatal respiratory morbidity Secondary endpoints: * Umbilical cord blood copeptin levels * Postnatal neonatal weight change * Breastfeeding status

Interventions

OTHEROxytocin challenge test (OCT)

Infusion of oxytocin 5 IU/500 ml Ringer® lactate at a rate of 12 ml/h and doubled every 10 min until three uterine contractions per 10-min interval are induced, at which point it will be stopped.

Sponsors

University of Basel
CollaboratorOTHER
University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Singleton pregnancy \>34 weeks * primary caesarean section, that is without preceding contractions or rupture of the membranes, * absence of a contraindication to oxytocin

Exclusion criteria

* Chromosomal aberration * malformation, * IUGR, * Nonreassuring fetal heart rate pattern, * Placenta praevia, * maternal substance abuse, * infections, * hypertension, * preeclampsia, * diabetes type I or II, * autoimmune disease (antiphospholipid syndrome, lupus erythematosus, etc.), * renal disease, * history of more than one previous caesarean section.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of neonatal respiratory morbidityin the first 4 hours of lifePercentage of infants to be monitored or admitted to neonatology for respiratory distress syndrome

Secondary

MeasureTime frameDescription
Umbilical cord blood copeptin levelsblood sample within 30 minutes after birthcopeptin levels in pmol/l
Postnatal neonatal weight changepostnatal day 1-4Maximum neonatal weight change in percent of birth weight
Breastfeeding status1 yearPercentage of children who are not, partially or full breastfed

Countries

Switzerland

Contacts

Primary ContactTilo Burkhardt, MD
tilo.burkhardt@usz.ch+41 44 255 5192
Backup ContactSven Wellmann, Prof
sven.wellmann@ukbb.ch+41 61 704 29 24

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026